Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company is engaged in acquiring, developing and commercializing products in cardiovascular, pain and other specialty areas. The Company's cardiovascular health products include Bezalip SR, Fibricor, Viskazide, Visken and Yosprala. The Company's pain management products include Cambia, Durela, Fiorinal, Fiorinal C, MT400, Treximet and Vimovo. The Company's other products include Balanse, Balanse Diaflor, Balanse Kids, Collatamp G, Iberogast, Ibsium, MoviPrep, Mutaflor, NeoVisc, Normacol, PegaLAX, Proferrin, Purfem, Resultz, Soriatane and Uracyst. The Company's product, Bezalip SR (bezafibrate), is a pan-peroxisome proliferator-activated receptor (pan-PPAR) activator. The VIMOVO is the brand name for a fixed dose combination of the proton pump inhibitor (PPI) esomeprazole magnesium with the non-steroidal anti-inflammatory drug (NSAID) naproxen in a single tablet.